WO2008033058A3 - Procédé permettant de produire une préparation d'insuline pour administration orale - Google Patents

Procédé permettant de produire une préparation d'insuline pour administration orale Download PDF

Info

Publication number
WO2008033058A3
WO2008033058A3 PCT/RU2007/000483 RU2007000483W WO2008033058A3 WO 2008033058 A3 WO2008033058 A3 WO 2008033058A3 RU 2007000483 W RU2007000483 W RU 2007000483W WO 2008033058 A3 WO2008033058 A3 WO 2008033058A3
Authority
WO
WIPO (PCT)
Prior art keywords
insulin
ranges
oral preparation
producing insulin
mrad
Prior art date
Application number
PCT/RU2007/000483
Other languages
English (en)
French (fr)
Other versions
WO2008033058A2 (fr
Inventor
Andrei Vladimirovich Artamonov
Petr Ivanovich Rodionov
Original Assignee
Concern O3 Company Ltd
Andrei Vladimirovich Artamonov
Petr Ivanovich Rodionov
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Concern O3 Company Ltd, Andrei Vladimirovich Artamonov, Petr Ivanovich Rodionov filed Critical Concern O3 Company Ltd
Priority to CA002662799A priority Critical patent/CA2662799A1/en
Priority to BRPI0714268-4A priority patent/BRPI0714268A2/pt
Priority to MX2009001286A priority patent/MX2009001286A/es
Priority to EA200801259A priority patent/EA012884B1/ru
Priority to AU2007295132A priority patent/AU2007295132A1/en
Priority to JP2009528195A priority patent/JP2010503665A/ja
Priority to US12/310,892 priority patent/US20090312235A1/en
Priority to EP07834992A priority patent/EP2067484A4/de
Publication of WO2008033058A2 publication Critical patent/WO2008033058A2/ru
Publication of WO2008033058A3 publication Critical patent/WO2008033058A3/ru
Priority to IL197470A priority patent/IL197470A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
PCT/RU2007/000483 2006-09-13 2007-09-11 Procédé permettant de produire une préparation d'insuline pour administration orale WO2008033058A2 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
CA002662799A CA2662799A1 (en) 2006-09-13 2007-09-11 Method for producing insulin in the form of an oral preparation
BRPI0714268-4A BRPI0714268A2 (pt) 2006-09-13 2007-09-11 método de obtenção do preparado de isulina administrado por via oral
MX2009001286A MX2009001286A (es) 2006-09-13 2007-09-11 Metodo de obtener preparado de insulina para aplicacion peroral.
EA200801259A EA012884B1 (ru) 2006-09-13 2007-09-11 Способ получения препарата инсулина для перорального применения
AU2007295132A AU2007295132A1 (en) 2006-09-13 2007-09-11 Method for producing insulin in the form of an oral preparation
JP2009528195A JP2010503665A (ja) 2006-09-13 2007-09-11 経口剤の形状でインスリンを作製する方法
US12/310,892 US20090312235A1 (en) 2006-09-13 2007-09-11 Method for producing insulin in the form of an oral preparation
EP07834992A EP2067484A4 (de) 2006-09-13 2007-09-11 Verfahren zur herstellung von insulin in form einer oralen zubereitung
IL197470A IL197470A0 (en) 2006-09-13 2009-03-08 Method for producing insulin in the form of an oral preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2006132763 2006-09-13
RU2006132763/15A RU2316339C1 (ru) 2006-09-13 2006-09-13 Способ получения препарата инсулина для перорального применения

Publications (2)

Publication Number Publication Date
WO2008033058A2 WO2008033058A2 (fr) 2008-03-20
WO2008033058A3 true WO2008033058A3 (fr) 2008-05-08

Family

ID=39184228

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RU2007/000483 WO2008033058A2 (fr) 2006-09-13 2007-09-11 Procédé permettant de produire une préparation d'insuline pour administration orale

Country Status (13)

Country Link
US (1) US20090312235A1 (ru)
EP (1) EP2067484A4 (ru)
JP (1) JP2010503665A (ru)
CN (1) CN101384276A (ru)
AU (1) AU2007295132A1 (ru)
CA (1) CA2662799A1 (ru)
EA (1) EA012884B1 (ru)
IL (1) IL197470A0 (ru)
MX (1) MX2009001286A (ru)
RU (1) RU2316339C1 (ru)
UA (1) UA93254C2 (ru)
WO (1) WO2008033058A2 (ru)
ZA (1) ZA200807272B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA90013C2 (ru) 2008-03-19 2010-03-25 Давид Анатолійович Нога Фармацевтическая композиция, содержащая инсулин, и способ его получения
RU2395296C1 (ru) * 2009-02-19 2010-07-27 Общество С Ограниченной Ответственностью "Концерн О3" Способ получения препарата проинсулина для перорального применения
RU2452509C1 (ru) * 2011-01-31 2012-06-10 Общество с ограниченной ответственностью "Саентифик Фьючер Менеджмент" ООО "Саентифик Фьючер Менеджмент" Средство для стимуляции роста организма
CA2859156C (en) * 2011-12-12 2020-10-06 Melior Pharmaceuticals I, Inc. Treatment of type i and type ii diabetes

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2066551C1 (ru) * 1994-03-23 1996-09-20 Институт нефтехимического синтеза РАН Способ получения инсулинсодержащих полимерных гидрогелей
RU2117488C1 (ru) * 1997-07-30 1998-08-20 Институт нефтехимического синтеза им.А.В.Топчиева РАН Твердое инсулинсодержащее лекарственное средство

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2213557C2 (ru) * 2001-12-26 2003-10-10 Закрытое акционерное общество "Аксис" Фармацевтическая композиция, обладающая тромболитическими, противовоспалительными и цитопротективными свойствами

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2066551C1 (ru) * 1994-03-23 1996-09-20 Институт нефтехимического синтеза РАН Способ получения инсулинсодержащих полимерных гидрогелей
RU2117488C1 (ru) * 1997-07-30 1998-08-20 Институт нефтехимического синтеза им.А.В.Топчиева РАН Твердое инсулинсодержащее лекарственное средство

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GREENLEY R.Z. ET AL.: "Polymer matrices for oral delivery", POLYMER PREPRINTS, vol. 31, 1990, pages 182 - 183, XP008104184 *

Also Published As

Publication number Publication date
IL197470A0 (en) 2011-08-01
CA2662799A1 (en) 2008-03-20
JP2010503665A (ja) 2010-02-04
EP2067484A4 (de) 2009-10-28
CN101384276A (zh) 2009-03-11
EP2067484A2 (de) 2009-06-10
EA012884B1 (ru) 2009-12-30
ZA200807272B (en) 2009-07-29
RU2316339C1 (ru) 2008-02-10
AU2007295132A1 (en) 2008-03-20
UA93254C2 (ru) 2011-01-25
US20090312235A1 (en) 2009-12-17
WO2008033058A2 (fr) 2008-03-20
MX2009001286A (es) 2009-03-20
EA200801259A1 (ru) 2008-08-29

Similar Documents

Publication Publication Date Title
CN102573913B (zh) 可生物降解的基于聚乙二醇的水不溶性水凝胶
CA2843875C (en) High-loading water-soluble carrier-linked prodrugs
ATE424848T1 (de) Pharmazeutische zusammensetzungen für die kontrollierte freigabe von biologischen wirkstoffen
WO2008009476A3 (de) Konzentrierte methotrexat-lösungen
WO2008103409A3 (en) Compositions of chloroquine coupled to antibodies and to other proteins with methods for their synthesis
EA200700389A1 (ru) Стабильный при хранении инфузионный раствор дигидроптеридинонов
TW200517142A (en) Amorphous, spray-dried powders having a reduced moisture content and a high-long term stability
US20140243254A1 (en) Polymeric Hyperbranched Carrier-Linked Prodrugs
GB0814302D0 (en) Compounds and methods
ATE438385T1 (de) Pharmazeutische zusammensetzung
KR102088107B1 (ko) 염증 억제 펩타이드의 물리적/화학적 함유 주사 제형 전달체, 이의 제조 방법 및 응용
HUP0105173A2 (hu) Adagolási módszer és készítmény sürgősségi fogamzásgátlásra
WO2008033058A3 (fr) Procédé permettant de produire une préparation d'insuline pour administration orale
MX2021014332A (es) Formulaciones estabilizadas que contienen anticuerpos anti-angptl3.
WO2009145594A3 (ko) 약물전달체
RU2008117161A (ru) Новая парентеральная композиция карбамазепина
DE60111637D1 (de) Biomaterial in form von mikropartikeln von hyaluronsaure zur medizinischen verwendung
EP3743072B1 (en) Pharmaceutical composition for sustained release delivery of buprenorphine
EP1996014B1 (en) Composition for treating bacterial, viral, fungal diseases, inflammation and pain
Dygai et al. Hemostimulating effects of Erythropoietin immobilized by the Nanotechnology method of electron-beam synthesis
KR20100044261A (ko) Ｇ-ｃｓｆ의 액상 조성물
Boothe et al. Analytical characterization, safety and clinical bioequivalence of recombinant human insulin from transgenic plants
TW201004656A (en) A stable fluid composition of taxane derivatives, preparing method and use thereof
CA2672707A1 (en) Oral delivery of protein drug using microemulsion
CN112040958A (zh) 含肽调配物

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07834992

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 200801259

Country of ref document: EA

WWE Wipo information: entry into national phase

Ref document number: 200780006039.2

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: MX/A/2009/001286

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 396/MUMNP/2009

Country of ref document: IN

ENP Entry into the national phase

Ref document number: 2009528195

Country of ref document: JP

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2662799

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2007295132

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 12310892

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2007834992

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2007295132

Country of ref document: AU

Date of ref document: 20070911

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: PI0714268

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20090210